Atrium Therapeutics, Inc. (RNA)

13.04 -0.26 (-1.95%) USD  |  NASDAQ  |  May 14, 11:11
More

Atrium Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for RNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
KalVista Pharmaceuticals, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Tango Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade